Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
Tan, D.S.W., Lassen, U.N., Albert, C.M., Kummar, S., van Tilburg, C., Dubois, S.G., Geoerger, B., Mascarenhas, L., Federman, N., Basu-Mallick, A., Doz, F., Berlin, J.D., Oh, D.-Y., Bielack, S., McDermott, R., Cruickshank, S., Ku, N.C., Cox, M.C., Drilon, A., Hong, D.S.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
Lassen, U N, Albert, C M, Kummar, S, van Tilburg, C M, Dubois, S G, Geoerger, B, Mascarenhas, L, Federman, N, Schilder, R J, Doz, F, Berlin, J D, Oh, D-Y, Bielack, S S, McDermott, R, Tan, D S, Cruickshank, S, Ku, N C, Cox, M C, Drilon, A, Hong, D S
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Vietnamese Manicurists: Are Immigrants Displacing Natives or Finding New Nails to Polish?
Federman, Maya N., Harrington, David E., Krynski, Kathy J.
Published in Industrial & labor relations review (01.01.2006)
Published in Industrial & labor relations review (01.01.2006)
Get full text
Journal Article
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
Drilon, Alexander, Laetsch, Theodore W, Kummar, Shivaani, DuBois, Steven G, Lassen, Ulrik N, Demetri, George D, Nathenson, Michael, Doebele, Robert C, Farago, Anna F, Pappo, Alberto S, Turpin, Brian, Dowlati, Afshin, Brose, Marcia S, Mascarenhas, Leo, Federman, Noah, Berlin, Jordan, El-Deiry, Wafik S, Baik, Christina, Deeken, John, Boni, Valentina, Nagasubramanian, Ramamoorthy, Taylor, Matthew, Rudzinski, Erin R, Meric-Bernstam, Funda, Sohal, Davendra P.S, Ma, Patrick C, Raez, Luis E, Hechtman, Jaclyn F, Benayed, Ryma, Ladanyi, Marc, Tuch, Brian B, Ebata, Kevin, Cruickshank, Scott, Ku, Nora C, Cox, Michael C, Hawkins, Douglas S, Hong, David S, Hyman, David M
Published in The New England journal of medicine (22.02.2018)
Published in The New England journal of medicine (22.02.2018)
Get full text
Journal Article
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
Gounder, Mrinal, Ratan, Ravin, Alcindor, Thierry, Schöffski, Patrick, van der Graaf, Winette T., Wilky, Breelyn A., Riedel, Richard F., Lim, Allison, Smith, L. Mary, Moody, Stephanie, Attia, Steven, Chawla, Sant, D’Amato, Gina, Federman, Noah, Merriam, Priscilla, Van Tine, Brian A., Vincenzi, Bruno, Benson, Charlotte, Bui, Nam Quoc, Chugh, Rashmi, Tinoco, Gabriel, Charlson, John, Dileo, Palma, Hartner, Lee, Lapeire, Lore, Mazzeo, Filomena, Palmerini, Emanuela, Reichardt, Peter, Stacchiotti, Silvia, Bailey, Howard H., Burgess, Melissa A., Cote, Gregory M., Davis, Lara E., Deshpande, Hari, Gelderblom, Hans, Grignani, Giovanni, Loggers, Elizabeth, Philip, Tony, Pressey, Joseph G., Kummar, Shivaani, Kasper, Bernd
Published in The New England journal of medicine (09.03.2023)
Published in The New England journal of medicine (09.03.2023)
Get full text
Journal Article
463P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up
McDermott, R.S., van Tilburg, C., Lin, J.J., Kummar, S., Tan, D.S.W., Albert, C.M., Berlin, J.D., Lassen, U.N., Doz, F., Geoerger, B., Mascarenhas, L., Federman, N., Norenberg, R., Dima, L., Mussi, C., De La Cuesta, E.A., Laetsch, T., Hong, D.S., Drilon, A.E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma
Ludwig, J.A., Federman, N., Anderson, P., Macy, M.E., Davis, L.E., Riedel, R.F., Muscal, J.A., Daw, N.C., Ratan, R., Toretsky, J., Ianopulos, X., Hsu, F.J., Breitmeyer, J.B., Meyers, P.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
LBA2 DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)
Kasper, B., Ratan, R., Alcindor, T., Schoeffski, P., van der Graaf, W.T.A., Wilky, B.A., Riedel, R.F., Lim, A., Smith, L.M., Moody, S., Attia, S., Chawla, S.P., D'Amato, G., Federman, N., Van Tine, P., Van Tine, B.A., Vincenzi, B., Kummar, S., Gounder, M.M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1955P Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer
McDermott, R., van Tilburg, C.M., Farago, A.F., Kummar, S., Tan, D.S.W., Albert, C.M., Berlin, J., Lassen, U.N., Doz, F., Geoerger, B., Mascarenhas, L., Federman, N., Reeves, J.A., Dima, L., Brega, N., De La Cuesta, E., Laetsch, T.W., Hong, D.S., Drilon, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
136P Efficacy and safety of larotrectinib (laro) as first-line treatment for paediatric (paed) patients (pts) with TRK fusion cancer
Orbach, D., Zwaan, C.M., Albert, C.M., Federman, N., Pappo, A., Bernard-Gauthier, V., Neu, N., De La Cuesta, E.A., Laetsch, T., Zhang, Y.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
Alternativas logísticas para el transporte de granos
Ayala, Ezequiel, Federman, Darío N., Mangiameli, Juan F., Marcó, Federico
Published in Revista Transporte y Territorio (01.10.2019)
Published in Revista Transporte y Territorio (01.10.2019)
Get full text
Journal Article
B02 The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Momcilovic, M., Lee, J.T., Braas, D., Graeber, T.G., Parlati, F., Demo, S., Li, R., Gricowski, M., Shuman, R., Ibarra, J., Fridman, D., St.John, M., Bernthal, N., Federman, N., Yanagawa, J., Dubinett, S.M., Sadeghi, S., Christofk, H.R., Shackelford, D.B.
Published in Journal of thoracic oncology (01.02.2020)
Published in Journal of thoracic oncology (01.02.2020)
Get full text
Journal Article
69OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
Tan, D S W, Lassen, U N, Albert, C M, Kummar, S, van Tilburg, C, Dubois, S G, Geoerger, B, Mascarenhas, L, Federman, N, Basu-Mallick, A, Doz, F, Berlin, J D, Oh, D-Y, Bielack, S, McDermott, R, Cruickshank, S, Ku, N C, Cox, M C, Drilon, A, Hong, D S
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
409OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
Lassen, U N, Albert, C M, Kummar, S, van Tilburg, C M, Dubois, S G, Geoerger, B, Mascarenhas, L, Federman, N, Schilder, R J, Doz, F, Berlin, J D, Oh, D-Y, Bielack, S S, McDermott, R, Tan, D S, Cruickshank, S, Ku, N C, Cox, M C, Drilon, A, Hong, D S
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia
Shankar, Deepa B., Cheng, Jerry C., Kinjo, Kentaro, Federman, Noah, Moore, Theodore B., Gill, Amandip, Rao, Nagesh P., Landaw, Elliot M., Sakamoto, Kathleen M.
Published in Cancer cell (01.04.2005)
Published in Cancer cell (01.04.2005)
Get full text
Journal Article
Phase 1/2 study of the selective TRK inhibitor larotrectinib, in pediatric patients with cancer
Gallego Mélcon, S., Casanova, M., Bielack, S., Chisholm, J., van Tilburg, C.S., Federman, N., Albert, C.M., Mascarenhas, L., Turpin, B., Nagasubramanian, R., Shukla, N., Spunt, S., Cox, M.C., Hawkins, D.S., Pappo, A.S., Doz, F., Bisogno, G., Dubois, S.G., Laetsch, T.W., Geoerger, B.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article